ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis.

PubWeight™: 3.60‹?› | Rank: Top 1%

🔗 View Article (PMID 24748319)

Published in World J Surg on June 01, 2014

Authors

Erik Schadde1, Victoria Ardiles, Ksenija Slankamenac, Christoph Tschuor, Gregory Sergeant, Nadja Amacker, Janine Baumgart, Kris Croome, Roberto Hernandez-Alejandro, Hauke Lang, Eduardo de Santibaňes, Pierre-Alain Clavien

Author Affiliations

1: Department of Surgery and Transplantation, Swiss HPB Center, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Associated clinical trials:

ALPPS: Safety, Feasibility and Efficacy at a Single Center | NCT02164292

Articles citing this

ALPPS: Adverse Outcomes Demand Clear Justification in an Era of Improving Survival for Colorectal Liver Metastases. World J Surg (2015) 1.18

Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function. Eur Radiol (2017) 0.98

Totally laparoscopic ALPPS in the treatment of cirrhotic hepatocellular carcinoma. Surg Endosc (2014) 0.93

Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis. HPB (Oxford) (2015) 0.92

Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review. World J Gastroenterol (2015) 0.91

Monitoring of liver function in a 73-year old patient undergoing 'Associating Liver Partition and Portal vein ligation for Staged hepatectomy': case report applying the novel liver maximum function capacity test. Patient Saf Surg (2016) 0.90

Small for size liver remnant following resection: prevention and management. Hepatobiliary Surg Nutr (2014) 0.87

ALPPS and simultaneous right hemicolectomy - step one and resection of the primary colon cancer. World J Surg Oncol (2015) 0.86

ALPPS Procedure for Extended Liver Resections: A Single Centre Experience and a Systematic Review. PLoS One (2015) 0.86

Patient Survival After Simultaneous ALPPS and Colorectal Resection. World J Surg (2016) 0.85

Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversy. World J Hepatol (2016) 0.84

ALPPS Offers a Better Chance of Complete Resection in Patients with Primarily Unresectable Liver Tumors. Results of a Multicentre Analysis: Reply. World J Surg (2015) 0.83

An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence. Medicine (Baltimore) (2016) 0.80

Outcomes of resection of giant hepatocellular carcinoma in a tertiary institution: does size matter? HPB (Oxford) (2015) 0.80

Intraoperative Conversion to ALPPS in a Case of Intrahepatic Cholangiocarcinoma. Case Rep Surg (2015) 0.79

Improved liver function after portal vein embolization and an elective right hepatectomy. HPB (Oxford) (2015) 0.79

The ALPPS approach: should we sacrifice basic therapeutic rules in the name of innovation? World J Surg (2014) 0.79

How we do it: double in situ split for staged mesohepatectomy in patients with advanced gall bladder cancer and marginal future liver remnant. Langenbecks Arch Surg (2016) 0.78

Two-stage hepatectomy for liver metastasis from colorectal cancer. CMAJ (2014) 0.78

Long-term results after in-situ split (ISS) liver resection. Langenbecks Arch Surg (2015) 0.78

Associated Liver Partition and Portal Vein Ligation (ALPPS) vs Selective Portal Vein Ligation (PVL) for Staged Hepatectomy in a Rat Model. Similar Regenerative Response? PLoS One (2015) 0.78

Surgery of Colorectal Liver Metastases: Pushing the Limits. Liver Cancer (2016) 0.78

Characterization of a porcine model for associating liver partition and portal vein ligation for a staged hepatectomy. HPB (Oxford) (2015) 0.78

The many faces of ALPPS: surgical indications and techniques among surgeons collaborating in the international registry. HPB (Oxford) (2016) 0.77

Evaluating surgeon attitudes towards the safety and efficacy of portal vein occlusion and associating liver partition and portal vein ligation: a report of the MALINSA survey. HPB (Oxford) (2015) 0.77

Associating liver partition and portal vein ligation for a patient with hepatocellular carcinoma with a background of hepatitis B related fibrotic liver. Int J Surg Case Rep (2014) 0.77

Inverting the ALPPS paradigm by minimizing first stage impact: the Mini-ALPPS technique. Langenbecks Arch Surg (2016) 0.76

A preliminary study of ALPPS procedure in a rat model. Sci Rep (2015) 0.76

The ALPPS procedure as a novel "liver-first" approach in treating liver metastases of colon cancer: the first experience in Greek Cypriot area. World J Surg Oncol (2016) 0.76

FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION. Arq Bras Cir Dig (2015) 0.76

ALPPS Procedure in Insufficient Hypertrophy After Portal Vein Embolization (PVE). World J Surg (2017) 0.76

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for hepatocellular carcinoma with chronic liver disease: a case report and review of literature. Korean J Hepatobiliary Pancreat Surg (2016) 0.75

ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases. World J Surg Oncol (2017) 0.75

The Future Liver Remnant in Patients Undergoing the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy (ALPPS) Maintains the Immunological Components of a Healthy Organ. Front Med (Lausanne) (2016) 0.75

Two-stage hepatectomy and associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) in treating liver metastases of rectal cancer: a case report. Springerplus (2015) 0.75

Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy. World J Gastroenterol (2016) 0.75

Associating liver partition and portal vein ligation for staged hepatectomy: From technical evolution to oncological benefit. World J Gastrointest Surg (2016) 0.75

Liver kinetic growth rate predicts postoperative liver failure after ALPPS. HPB (Oxford) (2016) 0.75

Early multifocal recurrence of hepatoblastoma in the residual liver after R0 liver resection with ALPPS procedure: a case report. Ann Transl Med (2016) 0.75

Strategies to increase the resectability of hepatocellular carcinoma. World J Hepatol (2015) 0.75

Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration. J Hepatocell Carcinoma (2016) 0.75

Associating microwave ablation and portal vein ligation for staged hepatectomy for the treatment of huge hepatocellular carcinoma with cirrhosis. Ann Surg Treat Res (2016) 0.75

Two cases of ALPPS procedure: simultaneous ALPPS and colorectal resection and ALPPS procedure for hepatic malignancy larger than 15 centimeter. Ann Hepatobiliary Pancreat Surg (2017) 0.75

Associating liver partition and portal vein ligation for staged hepatectomy: A surgical technique for liver resections. J Res Med Sci (2017) 0.75

The Impact of a Hepatobiliary Multidisciplinary Team Assessment in Patients with Colorectal Cancer Liver Metastases: A Population-Based Study. Oncologist (2017) 0.75

Combined Preoperative Portal and Hepatic Vein Embolization (Biembolization) to Improve Liver Regeneration Before Major Liver Resection: A Preliminary Report. World J Surg (2017) 0.75

Abdominal cross-sectional imaging of the associating liver partition and portal vein ligation for staged hepatectomy procedure. World J Hepatol (2017) 0.75

Articles cited by this

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13

Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg (2012) 19.78

Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg (2012) 3.87

The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg (2005) 3.46

Strategies for safer liver surgery and partial liver transplantation. N Engl J Med (2007) 3.14

Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07

An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer (2004) 3.06

Acute kidney injury. Lancet (2008) 2.44

High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol (2011) 2.28

The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg (2013) 2.27

Body surface area and body weight predict total liver volume in Western adults. Liver Transpl (2002) 2.21

Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg (2003) 2.20

A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg (2004) 2.20

Novel and simple preoperative score predicting complications after liver resection in noncirrhotic patients. Ann Surg (2010) 1.73

Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg (2008) 1.69

Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg (2008) 1.59

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? Ann Surg (2012) 1.55

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg (2012) 1.53

In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg (2012) 1.45

Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg (2013) 1.44

ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure? J Gastrointest Surg (2013) 1.32

Virtual liver resection and volumetric analysis of the future liver remnant using open source image processing software. World J Surg (2010) 1.18

Our initial experience with ALPPS technique: encouraging results. Updates Surg (2012) 1.11

Prospective volumetric assessment of the liver on a personal computer by nonradiologists prior to partial hepatectomy. World J Surg (2011) 1.04

Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB (Oxford) (2010) 1.04

Which limits to the "ALPPS" approach? Ann Surg (2012) 1.03

ALPPS procedure with the use of pneumoperitoneum. Ann Surg Oncol (2013) 0.98

Long-term results with associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Ann Surg (2012) 0.96

Associating liver partition and portal vein ligation for staged hepatectomy: will the morbidity of an additional surgery be outweighed by better patient outcomes in the long-term? Ann Surg (2012) 0.85

Note from the editors on the ALPPS e-Letters-to-the-Editor. Ann Surg (2012) 0.81

Using ALPPS to induce rapid liver hypertrophy in a patient with hepatic fibrosis and portal vein thrombosis. J Gastrointest Surg (2012) 0.77

Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg (2012) 0.76

Articles by these authors

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13

Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg (2012) 19.78

The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg (2009) 16.82

Obesity in general elective surgery. Lancet (2003) 7.22

No surgical innovation without evaluation: the IDEAL recommendations. Lancet (2009) 5.57

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol (2009) 5.57

Kidney transplantation from donors without a heartbeat. N Engl J Med (2002) 4.85

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology (2009) 4.03

Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg (2012) 3.87

Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg (2006) 3.35

Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med (2008) 3.10

Evaluation and stages of surgical innovations. Lancet (2009) 3.04

Platelet-derived serotonin mediates liver regeneration. Science (2006) 2.98

New staging system and a registry for perihilar cholangiocarcinoma. Hepatology (2011) 2.89

Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl (2002) 2.86

Challenges in evaluating surgical innovation. Lancet (2009) 2.86

A multicenter randomized clinical trial of primary anastomosis or Hartmann's procedure for perforated left colonic diverticulitis with purulent or fecal peritonitis. Ann Surg (2012) 2.82

A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell (2009) 2.64

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest (2006) 2.63

Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg (2007) 2.53

What is a surgical complication? World J Surg (2008) 2.53

Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg (2011) 2.51

Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg (2012) 2.49

Evidence-based value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses. Ann Surg (2004) 2.49

Protective strategies against ischemic injury of the liver. Gastroenterology (2003) 2.37

Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36

The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg (2013) 2.27

Donor information for living donor liver transplantation: where can comprehensive information be found? Liver Transpl (2012) 2.21

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg (2005) 2.18

How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg (2005) 2.16

Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant (2005) 2.06

Trainee satisfaction in surgery residency programs: modern management tools ensure trainee motivation and success. Surgery (2011) 2.04

Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts. Liver Transpl (2013) 2.03

Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int (2008) 1.95

Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation. World J Surg (2015) 1.95

Prospective evaluation of vacuum-assisted closure in abdominal compartment syndrome and severe abdominal sepsis. J Am Coll Surg (2007) 1.94

Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol (2006) 1.87

The White test: a new dye test for intraoperative detection of bile leakage during major liver resection. Arch Surg (2008) 1.86

Liver transplantation: the last measure in the treatment of bile duct injuries. World J Surg (2008) 1.84

Atraumatic chylous ascites: systematic review on symptoms and causes. J Am Coll Surg (2011) 1.83

Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis (2007) 1.80

Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg (2006) 1.79

From abstract to impact in cardiovascular research: factors predicting publication and citation. Eur Heart J (2012) 1.79

Superiority of small islets in human islet transplantation. Diabetes (2007) 1.76

Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl (2008) 1.75

The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl (2011) 1.75

Novel and simple preoperative score predicting complications after liver resection in noncirrhotic patients. Ann Surg (2010) 1.73

Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib. Int J Cancer (2005) 1.73

Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol (2007) 1.71

The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg (2011) 1.69

Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg (2014) 1.69

Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as rescue procedure for patients with failed laparoscopic gastric banding. Ann Surg (2003) 1.67

Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc Natl Acad Sci U S A (2011) 1.66

Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg (2004) 1.65

The correlation of nutrition risk index, nutrition risk score, and bioimpedance analysis with postoperative complications in patients undergoing gastrointestinal surgery. Surgery (2009) 1.63

High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol (2009) 1.62

MRI: the new reference standard in quantifying hepatic steatosis? Gut (2011) 1.61

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl (2002) 1.58

Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg (2009) 1.56

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut (2011) 1.56

Laparoscopic versus open splenectomy for nontraumatic diseases. World J Surg (2008) 1.55

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg (2012) 1.53

Low platelet counts after liver transplantation predict early posttransplant survival: the 60-5 criterion. Liver Transpl (2013) 1.49

Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. Gastroenterology (2010) 1.46

Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation (2008) 1.43

Rare PIK3CA hotspot mutations in carcinomas of the biliary tract. Genes Chromosomes Cancer (2008) 1.43

Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg (2007) 1.42

Systemic protection through remote ischemic preconditioning is spread by platelet-dependent signaling in mice. Hepatology (2014) 1.42

Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42

Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology (2002) 1.42

Novel approach using dissecting sealer for uncinate process resection during pancreaticoduodenectomy. J Am Coll Surg (2006) 1.40

New device for the introduction of a circular stapler in laparoscopic gastric bypass surgery. Obes Surg (2006) 1.40

A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg (2006) 1.39

Laparoscopic partial splenectomy. J Am Coll Surg (2006) 1.39

Diagnostic performance of a non-contrast-enhanced magnetic resonance imaging protocol for potential living related kidney donors. Acad Radiol (2013) 1.38

Retroperitoneal perforation of the colon caused by colonic tuberculosis: report of a case. Dis Colon Rectum (2004) 1.38

ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology (2003) 1.37

Minimally invasive versus open esophagectomy: meta-analysis of outcomes. Dig Dis Sci (2010) 1.35

Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology (2007) 1.35

Robotic-assisted versus laparoscopic cholecystectomy: outcome and cost analyses of a case-matched control study. Ann Surg (2008) 1.35

Right living donor liver transplantation: an option for adult patients: single institution experience with 74 patients. Ann Surg (2003) 1.31

Achalasia: will genetic studies provide insights? Hum Genet (2010) 1.30

Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg (2002) 1.29

A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg (2008) 1.28

Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation (2002) 1.27

Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg (2003) 1.27

Omega 3 - Omega 6: What is right for the liver? J Hepatol (2007) 1.26

Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 1.26

Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology (2010) 1.25

Assessment of a novel screening score for nutritional risk in predicting complications in gastro-intestinal surgery. Clin Nutr (2008) 1.24

Stapled vs excision hemorrhoidectomy: long-term results of a prospective randomized trial. Arch Surg (2002) 1.22

Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial. Ann Surg (2008) 1.21

Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl (2006) 1.20